These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36249621)

  • 41. Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations.
    Mols F; van den Hurk CJ; Vingerhoets AJ; Breed WP
    Support Care Cancer; 2009 Feb; 17(2):181-9. PubMed ID: 18560904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapy.
    Protière C; Evans K; Camerlo J; d'Ingrado MP; Macquart-Moulin G; Viens P; Maraninchi D; Genre D
    Support Care Cancer; 2002 Oct; 10(7):529-37. PubMed ID: 12324807
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hair and cancer chemotherapy: consequences and nursing care--a literature study.
    Batchelor D
    Eur J Cancer Care (Engl); 2001 Sep; 10(3):147-63. PubMed ID: 11829374
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health status, coping strategies, and alexithymia in subjects with androgenetic alopecia: a questionnaire study.
    Tabolli S; Sampogna F; di Pietro C; Mannooranparampil TJ; Ribuffo M; Abeni D
    Am J Clin Dermatol; 2013 Apr; 14(2):139-45. PubMed ID: 23413102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The physical, psychological and social experiences of alopecia among women receiving chemotherapy: An integrative literature review.
    Boland V; Brady AM; Drury A
    Eur J Oncol Nurs; 2020 Dec; 49():101840. PubMed ID: 33120213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. And It'll Come Back Real Baby Fine: Black Women's Experiences With Hair Loss and Regrowth After Chemotherapy for Breast Cancer Treatment.
    Wilson KB
    Qual Health Res; 2022 Jun; 32(7):1071-1085. PubMed ID: 35616447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of scalp cooling device to prevent alopecia for early breast cancer patients receiving chemotherapy: A prospective study.
    Giarratano T; Frezzini S; Zanocco M; Giorgi CA; Mioranza E; Miglietta F; Griguolo G; Falci C; Faggioni G; Tasca G; Di Liso E; Vernaci G; Menichetti A; Mantiero M; Grosso D; Guarneri V; Dieci MV
    Breast J; 2020 Jul; 26(7):1296-1301. PubMed ID: 31837103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients.
    Choi EK; Kim IR; Chang O; Kang D; Nam SJ; Lee JE; Lee SK; Im YH; Park YH; Yang JH; Cho J
    Psychooncology; 2014 Oct; 23(10):1103-10. PubMed ID: 24664939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer.
    Werbel T; Cohen PR
    Cureus; 2018 Jul; 10(7):e3056. PubMed ID: 30280054
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hair loss due to scalp ringworm irradiation in childhood: health and psychosocial risks for women.
    Hoffer L; Shvarts S; Segal-Engelchin D
    Isr J Health Policy Res; 2020 Jun; 9(1):34. PubMed ID: 32605644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Have men been overlooked? A comparison of young men and women's experiences of chemotherapy-induced alopecia.
    Hilton S; Hunt K; Emslie C; Salinas M; Ziebland S
    Psychooncology; 2008 Jun; 17(6):577-83. PubMed ID: 17957733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer - clinical evaluation of sensor-controlled scalp cooling.
    Friedrichs K; Carstensen MH
    Springerplus; 2014; 3():500. PubMed ID: 25279292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scalp hypothermia in the prevention of chemotherapy-induced alopecia.
    Vendelbo Johansen L
    Acta Radiol Oncol; 1985; 24(2):113-6. PubMed ID: 2988271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy-induced hair loss.
    Trüeb RM
    Skin Therapy Lett; 2010; 15(7):5-7. PubMed ID: 20700552
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Validation and Responsiveness of the English version of the Chemotherapy-Induced Alopecia Distress Scale (CADS) in Breast Cancer Patients.
    Kraehenbuehl L; Kang D; Bang AS; Ketosugbo KF; Hay J; Patil S; Goldfarb S; Cho J; Lacouture ME
    medRxiv; 2023 Nov; ():. PubMed ID: 37986836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized clinical trial of a videotape intervention for women with chemotherapy-induced alopecia: a gynecologic oncology group study.
    Nolte S; Donnelly J; Kelly S; Conley P; Cobb R
    Oncol Nurs Forum; 2006 Nov; 33(2):305-11. PubMed ID: 16518446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities: A Two-Year Survey of an Outpatient Cancer Center in Germany.
    Keim S; Hempel L; Ebner F; Retzer-Lidl M; Wohlmuth K; Hempel D; Milani V
    Oncol Res Treat; 2022; 45(7-8):395-399. PubMed ID: 35220298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Body image and psychological distress in women with breast cancer: a French online survey on patients' perceptions and expectations.
    Pierrisnard C; Baciuchka M; Mancini J; Rathelot P; Vanelle P; Montana M
    Breast Cancer; 2018 May; 25(3):303-308. PubMed ID: 29288390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of the DigniCap System in preventing chemotherapy-induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device.
    Pedersini R; Fornaro C; di Mauro P; Bianchi S; Vassalli L; Amoroso V; Gelmi M; Ardine M; Rodella F; Cosentini D; Dalla Volta A; Turla A; Pierini M; Motta P; Conti E; Simoncini EL; Berruti A
    Int J Nurs Pract; 2021 Jun; 27(3):e12888. PubMed ID: 32959460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of the CNC
    Petruzzi A; Mancuso AM; Alfieri S; Esposito A; Infante G; Miceli R; Ospitali S; Ripamonti CI; Borreani C
    BMC Womens Health; 2022 Dec; 22(1):492. PubMed ID: 36463143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.